Plus Therapeutics (PSTV) - חוב להון עצמי

This daily price chart for Plus Therapeutics, Inc. (PSTV) reflects a debt load of 0.07. Plus Therapeutics, Inc. (PSTV) is implementing proprietary radiopharmaceutical methods for tumor therapy to ensure a stable revenue stream. The business relies on growing clinical demand for targeted drug delivery, while AI-driven isotope synthesis automation is supplemented by mandatory medical patient support.

The total debt-to-equity ratio determines the business's level of dependence on borrowed funds, comparing total liabilities to net assets to assess financial stability. By analyzing the change in debt-to-equity at the 0.07 level, an investor can see the balance between the credit load and the resources required for Plus Therapeutics, Inc. (PSTV) to develop its unique targeted radiotherapy system for oncological surgery.